Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
not approved for human therapeutic or veterinary use
Most well-designed split-face trials run 8 to 12 weeks before reporting results
Transplantation 80, 653659
Your progress will be monitored in free reviews
Contrarily, generally no new vessels grew in BPC 157treated rats (i.e., those that did form in the limbus did not make contact with the penetrated area) (Masnec et al., 2015), showing that BPC 157 therapy may acknowledge also the angiogenic privilege of the corneal avascularity as essential for corneal wound healing (Tshionyi et al., 2012)
US$ 20.11
US$ 26.60
US$ 24.14
US$ 20.30
US$ 21.27
US$ 22.20
